A Phase 1/2 Study to Evaluate MEDI4736

NCT01693562 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1022

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: MEDI4736

Sponsor

MedImmune LLC